ALB and melanoma: The mechanisms governing the uptake of macromolecular therapeutic agents in human melanoma xenografts are currently being investigated in our laboratory, using albumin as a model molecule for macromolecular therapeutic agents (Graff et al, 2000, 2001; Bjørnæs and Rofstad, 2001).